ArticleCurrent medical science2023

Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: Expecting Its Application in Temporal Bone Squamous Cell Carcinoma.

Meng-Wen Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.